ADIPOQ and metabolic syndrome: Logistic regression statistical analysis showed an increased risk of percentage of metabolic syndrome in GG subjects (OR = 1.99, 95% CI = 1.21–4.11; p = 0.02) after adjusting for serum adiponectin, dietary energy intakes, gender, weight, and age of the patients with obesity.